Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 8251-8300 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05540392
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
PHASE1/PHASE2
Active, not recruiting
60 participants
Started: Sep 9, 2022 · Completed: Sep 30, 2026
2 conditions
1 sponsor
8 locations
NCT05434858
Imagery as Biomarker of Gout
NA
Active, not recruiting
21 participants
Started: Sep 9, 2022 · Completed: Sep 9, 2029
1 condition
2 sponsors
1 location
NCT05437406
Family, Responsibility, Education, Support, and Health for Latino Caregivers (FRESH-LC)
NA
Active, not recruiting
167 participants
Started: Sep 8, 2022 · Completed: Oct 31, 2026
2 conditions
5 sponsors
1 location
NCT05276973
Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer
PHASE1
Active, not recruiting
25 participants
Started: Sep 8, 2022 · Completed: Feb 26, 2026
18 conditions
2 sponsors
8 locations
NCT05272423
Studying Pathways of Resistance in KRAS-driven Cancers
N/A
Active, not recruiting
500 participants
Started: Sep 8, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT04788004
Long-term Recovery: Longitudinal Study of Neuro-behavioral Markers of Recovery and Precipitants of Relapse
N/A
Active, not recruiting
733 participants
Started: Sep 8, 2022 · Completed: Jul 20, 2026
1 condition
1 sponsor
1 location
NCT05454839
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
N/A
Active, not recruiting
1,098 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2026
1 condition
4 sponsors
2 locations
NCT05625737
Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma
PHASE2
Active, not recruiting
29 participants
Started: Sep 8, 2022 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT05528263
Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)
NA
Active, not recruiting
89 participants
Started: Sep 8, 2022 · Completed: Feb 28, 2026
6 conditions
2 sponsors
1 location
NCT05209074
Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma
PHASE1
Active, not recruiting
16 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05551052
CRC Detection Reliable Assessment With Blood
N/A
Active, not recruiting
196 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2027
16 conditions
1 sponsor
3 locations
NCT05570058
Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis
PHASE2
Active, not recruiting
48 participants
Started: Sep 8, 2022 · Completed: Jan 9, 2025
2 conditions
2 sponsors
31 locations
NCT05540782
A Study of Cognitive Health in Survivors of Prostate Cancer
N/A
Active, not recruiting
200 participants
Started: Sep 8, 2022 · Completed: Sep 8, 2026
2 conditions
1 sponsor
7 locations
NCT05561829
Determination of Optimal Sleep Treatment Elements - MOST
NA
Active, not recruiting
489 participants
Started: Sep 8, 2022 · Completed: May 31, 2024
1 condition
3 sponsors
1 location
NCT05442203
Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease
NA
Active, not recruiting
1,000 participants
Started: Sep 7, 2022 · Completed: Jul 31, 2025
2 conditions
1 sponsor
3 locations
NCT05621759
Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
PHASE2
Active, not recruiting
27 participants
Started: Sep 7, 2022 · Completed: Aug 23, 2026
1 condition
1 sponsor
1 location
NCT05264714
Cluster Headache Treatment With Rimegepant
PHASE2
Active, not recruiting
10 participants
Started: Sep 7, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05388760
Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)
PHASE2
Active, not recruiting
24 participants
Started: Sep 7, 2022 · Completed: Apr 23, 2026
1 condition
1 sponsor
11 locations
NCT05425940
Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer
PHASE3
Active, not recruiting
901 participants
Started: Sep 7, 2022 · Completed: Jan 31, 2027
1 condition
1 sponsor
133 locations
NCT05470283
Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
PHASE1
Active, not recruiting
21 participants
Started: Sep 7, 2022 · Completed: Apr 1, 2027
3 conditions
1 sponsor
1 location
NCT05621798
Quantifying the Benefits and Cost-effectiveness of Real-Ear Measurements (REM) for Hearing Aid Fitting
NA
Active, not recruiting
101 participants
Started: Sep 7, 2022 · Completed: Aug 31, 2025
1 condition
2 sponsors
1 location
NCT06303791
Digital-based Psychosocial Intervention for Parents of Children With Neurodevelopmental Disorders
NA
Active, not recruiting
90 participants
Started: Sep 7, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05566847
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
NA
Active, not recruiting
817 participants
Started: Sep 7, 2022 · Completed: Mar 31, 2025
1 condition
2 sponsors
1 location
NCT05434481
MITAORTA - Role of Mitochondrial Dynamic in Aneurysm and Dissection of Ascending Thoracic Aorta
NA
Active, not recruiting
60 participants
Started: Sep 7, 2022 · Completed: Oct 23, 2024
1 condition
2 sponsors
1 location
NCT05440643
Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy
PHASE1/PHASE2
Active, not recruiting
192 participants
Started: Sep 7, 2022 · Completed: Feb 28, 2026
1 condition
2 sponsors
40 locations
NCT04522739
Spironolactone Safety in African Americans with Mild Cognitive Impairment and Early Dementia
PHASE4
Active, not recruiting
30 participants
Started: Sep 6, 2022 · Completed: Oct 31, 2025
2 conditions
2 sponsors
1 location
NCT05503082
Ubrogepant treatmeNt in mIgraine Patients Utilizing mOnoclonal aNtibodies
PHASE4
Active, not recruiting
164 participants
Started: Sep 6, 2022 · Completed: Nov 30, 2024
1 condition
2 sponsors
2 locations
NCT04927364
Examining the Effectiveness of Deep TMS in Veterans With Alcohol Use Disorder
NA
Active, not recruiting
8 participants
Started: Sep 6, 2022 · Completed: Jul 1, 2025
2 conditions
2 sponsors
1 location
NCT05459298
ViDES Trial (Vitamin D Extra Supplementation)
NA
Active, not recruiting
180 participants
Started: Sep 6, 2022 · Completed: Dec 1, 2027
1 condition
3 sponsors
1 location
NCT05520528
Impact of Group Participation on Adults With Aphasia
NA
Active, not recruiting
40 participants
Started: Sep 6, 2022 · Completed: Dec 15, 2026
4 conditions
1 sponsor
1 location
NCT05316584
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy
NA
Active, not recruiting
123 participants
Started: Sep 6, 2022 · Completed: Jul 1, 2025
3 conditions
6 sponsors
5 locations
NCT05627128
A Culturally Tailored Dietary Intervention to Treat Crohn's Disease
NA
Active, not recruiting
150 participants
Started: Sep 6, 2022 · Completed: Nov 30, 2025
1 condition
3 sponsors
2 locations
NCT05471843
Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma
PHASE1/PHASE2
Active, not recruiting
125 participants
Started: Sep 5, 2022 · Completed: Jan 31, 2027
3 conditions
1 sponsor
104 locations
NCT05516264
Behavioural and Physiological Responses to Dog Visits in Nursing Homes
NA
Active, not recruiting
50 participants
Started: Sep 5, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05399381
Traveling-wave Transcranial Electric Stimulation
NA
Active, not recruiting
30 participants
Started: Sep 5, 2022 · Completed: Feb 1, 2026
1 condition
2 sponsors
1 location
NCT04074096
Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis
PHASE2
Active, not recruiting
10 participants
Started: Sep 5, 2022 · Completed: Apr 15, 2029
3 conditions
4 sponsors
21 locations
NCT05890274
Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO
NA
Active, not recruiting
120 participants
Started: Sep 4, 2022 · Completed: Feb 28, 2026
1 condition
4 sponsors
3 locations
NCT05156892
Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer
PHASE1
Active, not recruiting
44 participants
Started: Sep 4, 2022 · Completed: Jan 1, 2027
1 condition
5 sponsors
1 location
NCT05344183
Immediate and Short-term Effects of Low-level Laser
NA
Active, not recruiting
24 participants
Started: Sep 3, 2022 · Completed: Dec 12, 2024
2 conditions
1 sponsor
1 location
NCT05496959
177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study
PHASE2
Active, not recruiting
93 participants
Started: Sep 2, 2022 · Completed: Sep 1, 2033
4 conditions
2 sponsors
1 location
NCT06027567
The Effect of an Anti-obesity Drug, Semaglutide, As Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (dietician) with Regards to Change in Weight and Intracranial Pressure
PHASE4
Active, not recruiting
50 participants
Started: Sep 2, 2022 · Completed: Oct 30, 2025
6 conditions
4 sponsors
2 locations
NCT05398627
Neurofeedback for Borderline Personality Disorder
NA
Active, not recruiting
100 participants
Started: Sep 2, 2022 · Completed: Oct 31, 2025
1 condition
2 sponsors
1 location
NCT06116240
A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors
PHASE1
Active, not recruiting
135 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2023
1 condition
1 sponsor
12 locations
NCT05530551
Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With OA
NA
Active, not recruiting
20,000 participants
Started: Sep 1, 2022 · Completed: Mar 1, 2025
3 conditions
7 sponsors
36 locations
NCT05499949
The Franciscus Obesity NASH Study
N/A
Active, not recruiting
300 participants
Started: Sep 1, 2022 · Completed: Sep 1, 2029
3 conditions
4 sponsors
1 location
NCT05522426
Open Label, Multi-Center Study, Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Facial Fat Grafting
NA
Active, not recruiting
50 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT04271332
Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion
PHASE2
Active, not recruiting
60 participants
Started: Sep 1, 2022 · Completed: Mar 23, 2025
1 condition
1 sponsor
4 locations
NCT05673941
"InMotion - Physical Training With Creative Movement as an Intervention for Adults With Schizophrenia"
NA
Active, not recruiting
60 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT05545228
The Mouth Matters in Mental Health Study
NA
Active, not recruiting
79 participants
Started: Sep 1, 2022 · Completed: Jul 31, 2024
1 condition
1 sponsor
5 locations
NCT05445349
Breathing Parameter Measurements for Lung Deposition Simulation
N/A
Active, not recruiting
163 participants
Started: Sep 1, 2022 · Completed: Jun 30, 2025
2 conditions
7 sponsors
3 locations
Previous
1
More pages
163
164
165
166
167
168
169
More pages
431
Next